[Public Notice+] Neofect Registers Smart Balance, a Lower Limb Rehabilitation Device, with the US FDA... Expectation for Remote Medical Care Activation

[Asia Economy Reporter Hyunseok Yoo] Neofect announced on the 8th that its lower limb rehabilitation device, 'Smart Balance,' has been registered with the U.S. Food and Drug Administration (FDA).

Smart Balance is Neofect's first product in the lower limb rehabilitation line and is scheduled for official release later this month. It targets patients with musculoskeletal and neurological damage as well as elderly individuals with reduced balance ability. The device offers 16 rehabilitation games designed to train balance senses such as sitting and walking, and it evaluates the user's posture and gait. When imbalance is detected, it provides immediate feedback to guide users to train with the correct posture.

In particular, it is designed for use not only in medical clinics but also at home, enhancing treatment accessibility for patients with limited mobility and enabling convenient home rehabilitation. It was awarded the CES 2020 Innovation Award last January.

A Neofect representative stated, “We are continuously developing new products aiming to lead the telemedicine rehabilitation market and building a product lineup that covers the entire body. With this FDA registration, we have secured trust and global competitiveness for our products, allowing us to actively enter the lower limb rehabilitation market alongside our existing core upper limb rehabilitation devices.” He added, “Once patient data is collected through home rehabilitation using Smart Balance, it will be linked to Neofect’s tele-rehabilitation system in the future.”

Neofect is strengthening its strategy to target the U.S. market, which is expanding telemedicine support due to the spread of the novel coronavirus (COVID-19). On the 18th of last month, Neofect’s U.S. medical corporation, Community Rehab Care, received approval from the Massachusetts state government for insurance coverage of telemedicine costs related to COVID-19. Neofect plans to expand its telemedicine rehabilitation solution business centered on Community Rehab Care.

This content was produced with the assistance of AI translation services.